検索対象:     
報告書番号:
※ 半角英数字
 年 ~ 
 年

Energetic heavy ions overcome tumor radioresistance caused by overexpression of Bcl-2

Bcl-2過剰発現腫瘍の放射線抵抗性は重粒子線照射により消失する

浜田 信行*; 原 孝光*; 大村 素子*; 舟山 知夫; 坂下 哲哉; 楚良 桜; 横田 裕一郎; 中野 隆史*; 小林 泰彦

Hamada, Nobuyuki*; Hara, Takamitsu*; Omura, Motoko*; Funayama, Tomoo; Sakashita, Tetsuya; Sora, Sakura; Yokota, Yuichiro; Nakano, Takashi*; Kobayashi, Yasuhiko

Overexpression of Bcl-2 is frequent in human cancers and has been associated with the radioresistance. Here we investigated the potential impact of heavy ions on Bcl-2 overexpressing tumors. Bcl-2 cells (Bcl-2 overexpressing HeLa cells) and Neo cells (neomycin resistant gene-expressing HeLa cells) exposed to $$gamma$$-rays or heavy ions were assessed for the clonogenic survival, apoptosis and cell cycle distribution. Whereas Bcl-2 cells were more resistant to $$gamma$$-rays and helium ions (16.2 keV/$$mu$$m) than Neo cells, heavy ions (76.3-1610 keV/$$mu$$m) gave the comparable survival regardless of Bcl-2 overexpression. Carbon ions (108 keV/$$mu$$m) decreased the difference in the apoptotic incidence between Bcl-2 and Neo cells, and prolonged G$$_{2}$$/M arrest that occurred more extensively in Bcl-2 cells than in Neo cells. High-LET heavy ions overcome tumor radioresistance caused by Bcl-2 overexpression, which may be explained at least in part by the enhanced apoptotic response and prolonged G$$_{2}$$/M arrest. Thus, heavy-ion therapy may be a promising modality for Bcl-2 overexpressing radioresistant tumors.

Access

:

- Accesses

InCites™

:

パーセンタイル:39.03

分野:Oncology

Altmetrics

:

[CLARIVATE ANALYTICS], [WEB OF SCIENCE], [HIGHLY CITED PAPER & CUP LOGO] and [HOT PAPER & FIRE LOGO] are trademarks of Clarivate Analytics, and/or its affiliated company or companies, and used herein by permission and/or license.